SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001175707-23-000085
Filing Date
2023-02-14
Accepted
2023-02-14 15:25:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 13ga1_acumen.htm SC 13G/A 138578
  Complete submission text file 0001175707-23-000085.txt   140005
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92677 | Film No.: 23627888
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209
Business Address 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
Sands Capital Ventures, LLC (Filed by) CIK: 0001846444 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A